ID
25704
Descripción
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Palabras clave
Versiones (2)
- 11.09.17 11.09.17 -
- 11.09.17 11.09.17 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
11. September 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
visit period 1,2,3 & 4 cardiovascular monitoring day 1 PK and tolerability of ropinirole as 5 new formulations 101468/197
visit period 1,2,3 & 4 cardiovascular monitoring day 1 PK and tolerability of ropinirole as 5 new formulations 101468/197
Similar models
visit period 1,2,3 & 4 cardiovascular monitoring day 1 PK and tolerability of ropinirole as 5 new formulations 101468/197
C3469597 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
C0038846 (UMLS CUI [1,2])
C0038846 (UMLS CUI [1,2])
C0038846 (UMLS CUI [1,2])
C0231472 (UMLS CUI [1,2])
C0231472 (UMLS CUI [1,2])
C0231472 (UMLS CUI [1,2])
Sin comentarios